Clinical Trials
10 trialsNCT03803553 2026-05-01
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Phase 3 Recruiting
NCT05008809 2025-12-12
AIO-KRK-0418
Charite University, Berlin, Germany
Phase 3 Recruiting
NCT04389086 2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3 Recruiting
NCT05362617 2022-05-05
mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Unknown
NCT02453490 2020-07-14
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
Zhejiang University
Phase 3 Terminated
NCT00265850 2020-05-07
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02484833 2020-03-31
Erbitux MEtastatic Colorectal Cancer Strategy Study
Catholic University of the Sacred Heart
Phase 3 Completed
NCT01219920 2015-03-11
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest
Phase 3 Completed
NCT00313872 2012-01-12
Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer
Samsung Medical Center
Phase 3 Completed
NCT00374036 2011-10-12
Metastatic Gastric Cancer FFCD 03-07
University Hospital, Toulouse
Phase 3 Completed